# Junta clínica — PT-pseudo_ac05cda1a88a (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_ac05cda1a88a",
  "pid": "PT-pseudo_ac05cda1a88a",
  "task": 1,
  "psa": 14.5,
  "age": 44,
  "months": 3,
  "pirads": "5",
  "psad": 0.29,
  "psav": 6.16,
  "psap": 11.4,
  "vol": 51.0,
  "dre": "Nodus",
  "bx": "Positive",
  "cspca": 0.89338696,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 14.5 ng/mL. PI-RADS 5. PSAD 0.29. Prostate volume 51 mL. DRE nodus. csPCa 0.89.",
  "pmhx": [],
  "allergies": [],
  "vitals": {
    "weight": "67 kg",
    "height": "172 cm",
    "bmi": "22.6",
    "bp": "125/69 mmHg",
    "hr": "67 bpm",
    "smoking": "Non-smoker",
    "last_dental": "2 yr ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "17 Jan 2025",
  "enc_ref": "Dr. F. de Boer (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Persistent PSA elevation combined with a previously confirmed low-grade prostate malignancy prompted this clinical evaluation."
    },
    {
      "s": "History",
      "t": "A 44-year-old retired farmer seeks re-evaluation for a previously confirmed prostate malignancy and subsequent PSA increase. Marital status is divorced, though he currently resides with his partner, and his adult daughter acts as his main contact. Lower urinary tract symptoms reach an IPSS score of 15, chiefly due to nocturia and a diminished stream, while haematuria and pelvic discomfort are absent. Physical activity remains limited to occasional walking within a largely sedentary routine, alongside a weekly alcohol intake of roughly 15 units. Surgical history is minimal, featuring only a minor arthroscopic knee intervention during his thirties. He maintains a non-smoking status and carries a BMI of 22.6. Each clinic attendance demands a train journey exceeding one hour, necessitating extended consultation time."
    },
    {
      "s": "Physical examination",
      "t": "DRE reveals a firm, discrete nodule situated in the right mid-gland peripheral zone, while the remaining prostatic tissue feels symmetric and smooth. Vital parameters remain within normal limits, recording a blood pressure of 125/69 mmHg and a pulse of 67 bpm. The broader physical assessment shows no abdominal masses or palpable lymph node enlargement."
    }
  ],
  "occupation": "retired farmer",
  "marital": "Divorced",
  "living": "Lives with partner",
  "next_of_kin": "Adult daughter (primary contact)",
  "recent_other": [
    "Sleep clinic — suspected obstructive sleep apnoea"
  ],
  "alcohol": "15 units / week",
  "exercise": "Sedentary lifestyle, occasional walking",
  "ipss": "IPSS score: 15/35 (moderate LUTS)",
  "admin": "Patient travels 60+ min by train to clinic; allow buffer.",
  "mri_hospital": "Radboudumc",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_ac05cda1a88a
Task: 1

Encounter: Urology - outpatient on 17 Jan 2025.
Referrer: Dr. F. de Boer (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 44-year-old male
  - PSA: 14.5 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.29 ng/mL²
  - PSA velocity: 6.16 ng/mL/yr
  - Prior PSA: 11.4 ng/mL
  - Prostate volume: 51.0 mL
  - Months since last PSA: 3
  - DRE findings: Nodus (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.89338696 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 14.5 ng/mL. PI-RADS 5. PSAD 0.29. Prostate volume 51 mL. DRE nodus. csPCa 0.89.

Vitals: weight 67 kg, height 172 cm, BMI 22.6, BP 125/69 mmHg, HR 67 bpm. Smoking: Non-smoker.

Chief complaint: Persistent PSA elevation combined with a previously confirmed low-grade prostate malignancy prompted this clinical evaluation.

History: A 44-year-old retired farmer seeks re-evaluation for a previously confirmed prostate malignancy and subsequent PSA increase. Marital status is divorced, though he currently resides with his partner, and his adult daughter acts as his main contact. Lower urinary tract symptoms reach an IPSS score of 15, chiefly due to nocturia and a diminished stream, while haematuria and pelvic discomfort are absent. Physical activity remains limited to occasional walking within a largely sedentary routine, alongside a weekly alcohol intake of roughly 15 units. Surgical history is minimal, featuring only a minor arthroscopic knee intervention during his thirties. He maintains a non-smoking status and carries a BMI of 22.6. Each clinic attendance demands a train journey exceeding one hour, necessitating extended consultation time.

Physical examination: DRE reveals a firm, discrete nodule situated in the right mid-gland peripheral zone, while the remaining prostatic tissue feels symmetric and smooth. Vital parameters remain within normal limits, recording a blood pressure of 125/69 mmHg and a pulse of 67 bpm. The broader physical assessment shows no abdominal masses or palpable lymph node enlargement.

Patient info: retired farmer; Divorced; Lives with partner.
Next of kin: Adult daughter (primary contact).

Lifestyle: alcohol 15 units / week; exercise Sedentary lifestyle, occasional walking; IPSS score: 15/35 (moderate LUTS).

Recent other appointments: Sleep clinic — suspected obstructive sleep apnoea.
Admin: Patient travels 60+ min by train to clinic; allow buffer.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.51
  uncertainty  +/- 0.11 epistemic (95% band 0.30-0.72); among patients I cannot tell apart the outcome was 1.00 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = none recorded (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 44 (2% of my signal; from age) · DRE = Nodus (10% of my signal; from dre_suspicious) · PSA = 14.5 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 51 mL (1% of my signal; from log_vol, vol) · PSA density = 0.29 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.89 (1% of my signal; from cspca) · PI-RADS = 5 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 44 · DRE = Nodus · PSA = 14.5 ng/mL · prostate volume = 51 mL · PSA density = 0.29 · PI-RADS = 5 · comorbidity = none recorded
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 2.38: PI-RADS 5, PSA 8.7, PSAD 0.4, age 54, DRE Normal -> BIOPSY (uncertain). He wrote: "Young patient with high risk disease, should be recommended curative treatment. Biopsy report congruent with MRI, probably caught the index cancer at diagnosis. Highrisk…"
  2. distance 2.43: PI-RADS 5, PSA 4.53, PSAD 0.12, age 50, DRE Normal -> BIOPSY (clear). He wrote: "young patient with pirads5= high probability of significant prostate cancer and only one prev biopsy, increasing PSA. indicated with one more confirmatory biopsy to excl…"
  3. distance 2.46: PI-RADS 5, PSA 10.92, PSAD 0.26, age 61, DRE Nodus -> DEFER (clear). He wrote: "Advocate for curative treatment while unfavorable intermediate risk pc in young patient without significant comorbidity. IF he is cautious toward curative treatment, rep…"

PRECEDENT: BIOPSY (weighted vote 0.67 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   prior biopsy = Positive
  important  age = 44 · DRE = Nodus · PSA = 14.5 ng/mL · PSA density = 0.29 · PI-RADS = 5
  noted      family history = not opened (0 of 91) · prostate volume = 51 mL · csPCa probability = 0.89 · comorbidity = none recorded
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  decisive   prior biopsy = Positive
  important  age = 44 · DRE = Nodus · PSA = 14.5 ng/mL · PI-RADS = 5
  noted      family history = not opened (0 of 91) · prostate volume = 51 mL · PSA density = 0.29 · comorbidity = none recorded
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The EAU guidelines discuss the use of MRI and biopsy in the context of prostate cancer risk stratification. The retrieved text states, "sion on MRI mandates a repeat biopsy to confirm histological progression before a change in treatment strategy." This suggests that MRI findings can influence the decision for repeat biopsy.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, I see that the guideline treats the PI-RADS score as context, whereas EXPERT-STRUCTURED marked PI-RADS as decisive. The guideline suggests that a stable MRI (PRECISE 1-3) does not make repeat biopsy superfluous if the PSA-D is low. The guideline requires the prior grade of the biopsy to be established, which is a fact the panel does not represent.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the documented grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - the PSA velocity: a rising PSA velocity is a factor that the guideline considers in the overall risk assessment.
laboratory_results - the PSA density: the PSA density is a factor that the guideline uses in risk stratification.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

The case hinges on establishing the documented grade of the prior biopsy, as the cohort expert noted that the panel alone is insufficient.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Must state whether the lesion is compared against an earlier study.
  psa_trend (get_psa_trend) -> Must detail the PSA velocity to assess risk.
  previous_notes (get_previous_notes) -> Must document the grade of the prior biopsy (Gleason/ISUP) and surveillance status.

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade of the prior biopsy?
  Q2. Does the lesion in the radiology_report show progression compared to an earlier study?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
The lesion is compared against an earlier study: new
LESION
A 4 mm hypointense focus is noted in the right mid-gland peripheral zone, with a PI-RADS 5 focus.

psa_trend
The PSA velocity is rising, with values from "Nov 2022" at 2.4 ng/mL to "Jan 2025" at 14.5 ng/mL.

previous_notes
PRIOR GRADE: not recorded
BIOPSY SESSIONS: not recorded
SURVEILLANCE: not recorded
TREATMENT: none recorded

WHAT I DID NOT OPEN
family-history anamnesis, because the cohort expert noted it was not weighed by the reading urologist.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 5 finding from radiology_report
Rising PSA velocity from psa_trend

AGAINST sampling this patient now
Prior biopsy status is not documented in previous_notes, which is a critical missing piece.

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 14.50 ng/mL over 3 points spanning 26 months; velocity +5.58 ng/mL per year; doubling time about 10 months.
PROJECTION at 6 months: 24.5 ng/mL, conformal 95% band 7.0-85.2.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 14.5 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.63
  uncertainty  +/- 0.08 epistemic (95% band 0.47-0.79), of which 0.01 comes from values that had to be imputed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 56% of the time over the 25 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 5 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      PSA = 14.5 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 51 mL (4% of my signal; from log_vol, vol) · PSA density = 0.29 (0% of my signal; from psad_calc) · comorbidity = none recorded (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, DRE, csPCa probability
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 56% of the time over the 25 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.51  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.63  ('supports' tier, fusion_nolab; weight 3.0)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=0.67  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.60 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('supports' tier, fusion_nolab). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:DEC E2:—            -> decisive
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          44                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Nodus                        E1:not E3:— cohort:not library:IMP E2:—              -> not_used (raised from important by the board)
  psa          14.5 ng/mL                   E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          51 mL                        E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.29                         E1:not E3:not cohort:not library:IMP E2:—            -> noted
  cspca        0.89                         E1:not E3:— cohort:— library:not E2:—                -> not_used
  pirads       5                            E1:not E3:IMP cohort:not library:IMP E2:—            -> important
  comorbidity  none recorded                E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes) directly address the moderator's questions. The registrar reported that the `radiology_report` stated the lesion is "new" compared to an earlier study, and the `psa_trend` detailed a rising PSA velocity. The `previous_notes` explicitly stated that the "PRIOR GRADE: not recorded."

ALIGNMENT WITH THE PANEL
The PANEL-PROTOCOL concluded BIOPSY based on a weighted vote of 0.60, noting that the "documented prior grade in the opened documents: none recorded." The retrieved evidence confirms this gap, as the `previous_notes` explicitly state the prior grade is not recorded. The retrieved findings (new lesion, rising PSA velocity) support the leaning towards biopsy.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade of the prior biopsy? This question remains unanswered, as the `previous_notes` explicitly state the "PRIOR GRADE: not recorded." Q2. Does the lesion in the radiology_report show progression compared to an earlier study? The `radiology_report` states the lesion is "new" compared to an earlier study.

WHAT CARRIES WEIGHT, AND WHY
<prior biopsy>: not_used / not recorded (not recorded) because the `previous_notes` explicitly state "PRIOR GRADE: not recorded," which is the critical missing piece the cohort expert identified. I would move this to 'decisive' because the lack of documentation overrides the panel's reliance on the absence of a recorded grade.
<psa>: important / noted (14.5 ng/mL) because the PSA is important, and the Expert-PSA showed a rising trajectory, which supports the need for action.
<pirads>: important (5) because the PI-RADS 5 finding was weighted as important by the panel, indicating high imaging suspicion.
My confidence in the record as it stands is borderline, as the critical piece of information (prior biopsy grade) is explicitly missing, despite the panel's decision.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a biopsy, leaning towards a more firm recommendation than the panel's decision, because the lack of a documented prior biopsy grade, combined with a new lesion on MRI and rising PSA velocity, strongly supports the need for tissue confirmation.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

44y male, PSA 14.5, PI-RADS 5, prior positive biopsy with unrecorded grade. New lesion finding mandates repeat biopsy to determine management. Prior grade is not recorded, which is the driver for sampling.

What carried weight: bx=decisive, age=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
